Abstract
Low flow vascular malformations of the orbit are uncommon, yet vision threatening lesions, that are difficult to manage surgically by virtue of their infiltrative morphology and tendency to recur. With the recent availability of advanced image guidance tools in the angiography suite, sclerotherapy has emerged as a minimally invasive treatment option for these lesions. A multi-disciplinary approach involving oculoplastic surgery, ophthalmology and interventional radiology is recommended for optimal management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Wright JE, Sullivan TJ, Garner A, Wulc AE, Moseley IF. Orbital venous anomalies. ophthalmology [Internet]. American Academy of Ophthalmology, Inc; 1997;104(6):905–13. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0161642097302085.
Sekhar LN, Tariq F. Orbital lymphangiomas: surgical treatment and clinical outcome. World Neurosurg [Internet]. Elsevier Inc; 2014;81(5–6):710–1. Available from: http://dx.doi.org/10.1016/j.wneu.2013.02.090.
Greene AK, Burrows PE, Smith L, Mulliken JB. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg. 2005;115(1):22–30.
Greene AK, Perlyn CA, Alomari A, Greene AK, Perlyn CA, Alomari AI. Management of lymphatic malformations. Clin Plast Surg. 2011;38(1):75–82. Elsevier Ltd.
Russin JJ, Rangel-Castilla L, Kalani MYS, Spetzler RF. Surgical management, outcomes, and recurrence rate of orbital lymphangiomas. J Clin Neurosci [Internet]. Elsevier Ltd; 2015;22(5):877–82. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0967586814006791.
Schwarcz RM, Ben Simon GJ, Cook T, Goldberg RA. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit. Am J Ophthalmol [Internet]. 2006;141(2):333–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16458690.
Jia R, Xu S, Huang X, Song X, Pan H, Zhang L, et al. Pingyangmycin as first-line treatment for low-flow orbital or periorbital venous malformations: evaluation of 33 consecutive patients. JAMA Ophthalmol [Internet]. 2014;132(8):1–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24723045.
Rootman J, Heran MKS, Graeb DA. Vascular malformations of the orbit: classification and the role of imaging in diagnosis and treatment strategies*. Ophthal Plast Reconstr Surg [Internet]. 2014;30(2):91–104. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24614543.
Barnacle AM, Theodorou M, Maling SJ, Abou-Rayyah Y. Sclerotherapy treatment of orbital lymphatic malformations: a large single-centre experience. Br J Ophthalmol [Internet]. 2015;1–5. Available from: http://bjo.bmj.com/cgi/doi/10.1136/bjophthalmol-2015-306657.
Hill RH, Shiels WE, Czyz CN, Stacey A, Everman KR, Cahill KV. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations. Ophthal Plast Reconstr Surg. 2012;28(2):119–25.
Nassiri N, Rootman J, Rootman DB, Goldberg RA. Orbital lymphaticovenous malformations: Current and future treatments. Surv Ophthalmol [Internet]. Mosby, Inc; 2015; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0039625715000405.
Gündüz K, Demirel S, Yagmurlu B, Erden E. Correlation of surgical outcome with neuroimaging findings in periocular lymphangiomas. Ophthalmology [Internet]. 2006;113(7):1231.e1–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16730067.
Tunç M, Sadri E, Char DH. Orbital lymphangioma: an analysis of 26 patients. Br J Ophthalmol. 1999;83(1):76–80.
MacIntosh PW, Yoon MK, Fay A. Complications of intralesional bleomycin in the treatment of orbital lymphatic malformations. Semin Ophthalmol [Internet]. 2014;29(5-6):450–5. Available from: http://informahealthcare.com/doi/abs/10.3109/08820538.2014.959617.
Stacey AW, Gemmete JJ, Kahana A. Management of orbital and periocular vascular anomalies. Ophthal Plast Reconstr Surg [Internet]. 2015;31(6):427–36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26560200.
Sainsbury DCG, Kessell G, Fall AJ, Hampton FJ, Guhan A, Muir T. Intralesional bleomycin injection treatment for vascular birthmarks: a 5-year experience at a single United Kingdom unit. Plast Reconstr Surg. 2011;127(5):2031–44.
Shippee BM, Bates JS, Richards KL. The role of screening and monitoring for bleomycin pulmonary toxicity. J Oncol Pharm Pract [Internet]. 2015; Available from: http://opp.sagepub.com/cgi/doi/10.1177/1078155215574294.
Paramasivam S, Fay A, Fifi J, Berenstein A. O-015 image guided bleomycin sclerotherapy for orbital lymphatic malformation. J NeuroInterventional Surg [Internet]. 2014;6 (Suppl 1):A8–9. Available from: http://jnis.bmj.com/content/6/Suppl_1/A8.2.abstract.
Sainsbury DCG, Kessell G, Guhan A, Fall A, Miller V, Abouzeid MR, et al. Unexpected hyperpigmentation following intralesional bleomycin injection. J Plast Reconstr Aesthetic Surg. 2009;62(11):497–9.
Lightfoot CB, Ju Y, Dubois J, Abdolell M, Giroux M-F, Gilbert P, et al. Cone-beam CT: an additional imaging tool in the interventional treatment and management of low-flow vascular malformations. J Vasc Interv Radiol [Internet]. 2013;24(7):981–8.e2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23796086
Svendsen PA. Direct puncture and sclerotherapy with sotradecol ((r)). Orbital lymphatic malformations. Interv Neuroradiol. 2001;7:193–9.
Chiramel GK, Keshava SN, Moses V, Mammen S, David S, Sen S. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit. Cardiovasc Intervent Radiol. 2015;38:270–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Pimpalwar, S., Chinnadurai, P., Marx, D.P. (2016). Low-Flow Vascular Malformations of the Orbit: Evaluation and Management. In: Yen, M. (eds) Vascular Lesions of the Orbit and Face. Springer, Cham. https://doi.org/10.1007/978-3-319-29704-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-29704-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29702-6
Online ISBN: 978-3-319-29704-0
eBook Packages: MedicineMedicine (R0)